Baker Boyer National Bank’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $333K | Hold |
1,324
| – | – | 0.09% | 67 |
|
|
2026
Q1 | $288K | Sell |
1,324
-89
| -6% | -$19.7K | 0.09% | 72 |
|
|
2025
Q4 | $323K | Sell |
1,413
-170
| -11% | -$38.7K | 0.1% | 69 |
|
|
2025
Q3 | $367K | Buy |
1,583
+89
| +6% | +$18.1K | 0.12% | 60 |
|
|
2025
Q2 | $277K | Hold |
1,494
| – | – | 0.1% | 65 |
|
|
2025
Q1 | $313K | Hold |
1,494
| – | – | 0.12% | 60 |
|
|
2024
Q4 | $265K | Sell |
1,494
-190
| -11% | -$34.9K | 0.09% | 69 |
|
|
2024
Q3 | $333K | Hold |
1,684
| – | – | 0.11% | 64 |
|
|
2024
Q2 | $289K | Hold |
1,684
| – | – | 0.1% | 64 |
|
|
2024
Q1 | $307K | Sell |
1,684
-210
| -11% | -$36.2K | 0.11% | 70 |
|
|
2023
Q4 | $294K | Buy |
1,894
+250
| +15% | +$36.4K | 0.11% | 73 |
|
|
2023
Q3 | $245K | Buy |
1,644
+96
| +6% | +$14.1K | 0.1% | 75 |
|
|
2023
Q2 | $209K | Hold |
1,548
| – | – | 0.08% | 80 |
|
|
2023
Q1 | $247K | Hold |
1,548
| – | – | 0.1% | 74 |
|
|
2022
Q4 | $250K | Hold |
1,548
| – | – | 0.11% | 72 |
|
|
2022
Q3 | $208K | Sell |
1,548
-37
| -2% | -$5.31K | 0.09% | 76 |
|
|
2022
Q2 | $243K | Sell |
1,585
-753
| -32% | -$115K | 0.12% | 74 |
|
|
2022
Q1 | $379K | Sell |
2,338
-53
| -2% | -$7.7K | 0.18% | 58 |
|
|
2021
Q4 | $324K | Buy |
+2,391
| New | +$282K | 0.15% | 69 |
|
|
2021
Q2 | $243K | Buy |
+1,585
| New | +$179K | 0.12% | 74 |
|
|
2018
Q1 | $268K | Buy |
2,827
+16
| +0.6% | +$1.76K | 0.81% | 47 |
|
|
2017
Q4 | $272K | Hold |
2,811
| – | – | 0.82% | 42 |
|
|
2017
Q3 | $250K | Hold |
2,811
| – | – | 0.82% | 43 |
|
|
2017
Q2 | $204K | Buy |
+2,811
| New | +$189K | 0.81% | 41 |
|
|
2015
Q3 | – | Sell |
-3,532
| Closed | -$237K | – | 35 |
|
|
2015
Q2 | $237K | Hold |
3,532
| – | – | 0.49% | 46 |
|
|
2015
Q1 | $207K | Buy |
3,532
+137
| +4% | +$8.28K | 0.42% | 50 |
|
|
2014
Q4 | $222K | Sell |
3,395
-1,234
| -27% | -$77.8K | 0.43% | 48 |
|
|
2014
Q3 | $267K | Hold |
4,629
| – | – | 0.52% | 41 |
|
|
2014
Q2 | $262K | Hold |
4,629
| – | – | 0.48% | 46 |
|
|
2014
Q1 | $238K | Buy |
4,629
+40
| +0.9% | +$2.02K | 0.47% | 45 |
|
|
2013
Q4 | $242K | Sell |
4,589
-1,600
| -26% | -$78.6K | 0.47% | 42 |
|
|
2013
Q3 | $277K | Hold |
6,189
| – | – | 0.61% | 31 |
|
|
2013
Q2 | $257K | Buy |
+6,189
| New | +$271K | 0.55% | 34 |
|
Other funds holding ABBV
ECSS
ATO
Baker Boyer National Bank's ABBV Position: Q2 2026 in Review
Baker Boyer National Bank held its AbbVie (ABBV) position steady in Q2 2026 at 1,324 shares worth $333K. The position accounts for 0.09% of the portfolio, ranked #67.
Baker Boyer National Bank first reported a position in ABBV in Q2 2013 and has held it in 33 quarters since. The position peaked at $379K in Q1 2022. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Baker Boyer National Bank held 1,324 shares of AbbVie worth $333K as of Q2 2026.
- Baker Boyer National Bank left its AbbVie share count unchanged in Q2 2026.
- AbbVie made up 0.09% of Baker Boyer National Bank's portfolio in Q2 2026, its #67 holding.
- Baker Boyer National Bank first reported a position in AbbVie in Q2 2013 and has held it in 33 quarters since.
- Baker Boyer National Bank's AbbVie position peaked at $379K in Q1 2022.
- 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Baker Boyer National Bank's 13F filing for Q2 2026, filed 27 Jul 2026.